R&D
Study Shows Bayer’s Aliqopa, Rituximab Combo Improves Survival of Relapsed Lymphoma Patients
2021-04-10
Gilead’s Breast Cancer Drug that Came off a $21 Billion Buyout Finally Gets FDA’s Full Approval
2021-04-09
Canadian Biotech Launches Screening Panel for Detecting Multiple Cancers from Single Blood Sample
2021-04-07
Piramal Pharma Targets Peptide APIs Market, Acquires 100% Stake in India’s API Manufacturer Hemmo
2021-04-06